Skip to main content
. 2015 Oct 15;40(3):387–390. doi: 10.5114/ceji.2015.54604

Table 2.

Evaluation of humoral immune response before and after the intravenous immunoglobulin replacement therapy for the patient with a selective IgG1 subclass deficiency

Serum IgG (g/l) Serum IgG1 (g/l) Anti-HSV IgM (U/ml) Anti-HSV IgG (U/ml)
Before treatment 6 3.12 30.2 970000
After treatment 9.6 4.09 negative 3974